Q Holdings

Q Holdings engages in the development of human cell-based therapies for the treatment of degenerative diseases of the brain and spinal cord.

Q Holdings, Inc., a development stage company, engages in the development of human cell-based therapies for the treatment of degenerative diseases of the brain and spinal cord. The company develops Q-Cells that is intended for the treatment of amyotrophic lateral sclerosis, multiple sclerosis, transverse myelitis, traumatic spinal cord injury, and Parkinson’s disease, as well as for Alzheimer’s disease, traumatic brain injury, cerebral palsy, Leukodystrophies and central nervous system storage diseases, and peripheral neuropathies. Q Holdings, Inc. is headquartered in Salt Lake City, Utah.